These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25560582)

  • 1. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
    Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
    Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.
    Delozier TC; Kissling GE; Coulter SJ; Dai D; Foley JF; Bradbury JA; Murphy E; Steenbergen C; Zeldin DC; Goldstein JA
    Drug Metab Dispos; 2007 Apr; 35(4):682-8. PubMed ID: 17220242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.
    Lee CR; North KE; Bray MS; Couper DJ; Heiss G; Zeldin DC
    Pharmacogenet Genomics; 2007 May; 17(5):349-58. PubMed ID: 17429317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.
    Marciante KD; Totah RA; Heckbert SR; Smith NL; Lemaitre RN; Lumley T; Rice KM; Hindorff LA; Bis JC; Hartman B; Psaty BM
    Pharmacogenet Genomics; 2008 Jun; 18(6):535-43. PubMed ID: 18496133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.
    Dreisbach AW; Japa S; Sigel A; Parenti MB; Hess AE; Srinouanprachanh SL; Rettie AE; Kim H; Farin FM; Hamm LL; Lertora JJ
    Am J Hypertens; 2005 Oct; 18(10):1276-81. PubMed ID: 16202848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.
    King LM; Gainer JV; David GL; Dai D; Goldstein JA; Brown NJ; Zeldin DC
    Pharmacogenet Genomics; 2005 Jan; 15(1):7-13. PubMed ID: 15864120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variance in CYP2C8 and increased risk of myocardial infarction.
    Rodenburg EM; Visser LE; Danser AH; Hofman A; van Noord C; Witteman JC; Uitterlinden AG; Stricker BH
    Pharmacogenet Genomics; 2010 Jul; 20(7):426-34. PubMed ID: 20436375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.
    Ochoa D; Prieto-Pérez R; Román M; Talegón M; Rivas A; Galicia I; Abad-Santos F; Cabaleiro T
    Pharmacogenomics; 2015; 16(9):939-48. PubMed ID: 26122864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.
    Rao DK; Murthy DK; Shaik NS; Banaganapalli B; Konda K; Rao HP; Ganti E; Ahmed Awan Z; A El-Harouni A; Elango R; Ali Khan I; Shaik NA
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1171-1179. PubMed ID: 28686288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
    Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
    Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort.
    Haschke-Becher E; Kirchheiner J; Trummer O; Grünbacher G; Kainz A; Boehm BO; März W; Renner W
    Pharmacogenomics; 2010 Oct; 11(10):1359-65. PubMed ID: 21047199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-Specific Effect of CYP2C8*3 on the Risk of Essential Hypertension in Bulgarian Patients.
    Tzveova R; Naydenova G; Yaneva T; Dimitrov G; Vandeva S; Matrozova Y; Pendicheva-Duhlenska D; Popov I; Beltheva O; Naydenov C; Tarnovska-Kadreva R; Nachev G; Mitev V; Kaneva R
    Biochem Genet; 2015 Dec; 53(11-12):319-33. PubMed ID: 26404779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.
    García-Martín E; Martínez C; Ladero JM; Agúndez JA
    Mol Diagn Ther; 2006; 10(1):29-40. PubMed ID: 16646575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype structures of common variants of CYP2C8, CYP2C9, and ADRB1 genes in a South Indian population.
    Arun Kumar AS; Chakradhara Rao US; Umamaheswaran G; Ramu P; Kesavan R; Shewade DG; Balachandar J; Adithan C
    Genet Test Mol Biomarkers; 2011 Jun; 15(6):407-13. PubMed ID: 21375401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
    Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
    Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2C8 and CYP2J2 gene variations increase the risk of hypertensive intracerebral hemorrhage.
    Li Y; You C; Liu Z; He F; Zhao F; Song X; Xie Z; Wei S; Yang Y; Wei H; Che F; Yu J
    J Stroke Cerebrovasc Dis; 2023 Mar; 32(3):106974. PubMed ID: 36587509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.
    Kudzi W; Dodoo AN; Mills JJ
    BMC Med Genet; 2009 Dec; 10():124. PubMed ID: 19954515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in genes involved in vasoactive eicosanoid synthesis affect cardiovascular risk in renal transplant recipients.
    Gervasini G; Luna E; Garcia-Pino G; Azevedo L; Mota-Zamorano S; José Cubero J
    Curr Med Res Opin; 2018 Feb; 34(2):247-253. PubMed ID: 29022765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
    Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
    Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytochrome epoxygenase (CYP2J2) in the pathophysiology of coronary artery disease in South Indian population.
    Tantray JA; Reddy KP; Jamil K; Yerra SK
    Indian Heart J; 2019; 71(1):60-64. PubMed ID: 31000184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.